References
- Stewart BW, Kleihues P. World Cancer Report. International Agency for Research on Cancer. WHO, Lyon 2003
- Boyle P, d'Onofrio A, Maisonneuve P, Severi G, Robertson C, Tubiana M, et al. Measuring progress against cancer in Europe: Has the 15% decline targeted for 2000 come about?. Ann Oncol 2003; 14: 1312–25
- Survival of cancer patients in Europe: The EUROCARE-3 Study. Ann Oncol 2003;14(Suppl 5).
- WHO National Cancer Control Planning. International Union Against Cancer. 2004.
- Ward LC, Felding JW, Dunn JA, Kelly KA. The selection of cases for randomised trials: A registry survey of concurrent trial and non-trial patients. British Stomach Cancer Group. Br J Cancer 1992; 66: 943–50
- Tejeda HA, Green SB, Trimble EL, Ford L, High JL, Ungerleider RS, et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst 1996; 88: 812–6
- http://www.oeci-eeig.org.
- Pukkala E, Andersen A, Berglund G, Gislefoss R, Gudnason V, Hallmans G, et al. Nordic biological specimen banks as basis for studies of cancer causes and control – more than 2 million sample donors, 25 million person years and 100 000 prospective cancers. Acta Oncol 2007; 46: 286–307
- http://www.tubafrost.org.
- http://researchprojects.kth.se.
- http://www.fnclcc.fr.
- http:www.cancerresearchuk.org.
- http://www.e-oncology.it.
- Talbäck M, Stenbeck M, Rosén M, Barlow L, Glimelius B. Cancer survival in Sweden 1960–1998. Acta Oncol 2003; 42: 637–59
- Johansen C. Rehabilitation of cancer patients – research perspectives. Acta Oncol 2007; 46: 441–5